HIF1A and COVID-19: Lastly, several comorbidities, including obesity and pulmonary hypertension, increase pre-existing HIF1α levels, which SARS-CoV-2 infection exacerbates, perhaps explaining the vulnerability of this patient demographic to severe COVID-19 (89).